| Literature DB >> 33602987 |
Timon Damelang1, Elizabeth H Aitken2, Wina Hasang2, Ester Lopez1, Martin Killian1,3,4, Holger W Unger5,6,7, Ali Salanti8,9, Alexis Shub10, Elizabeth McCarthy10, Katherine Kedzierska1, Martha Lappas10, Stephen J Kent1,11, Stephen J Rogerson2, Amy W Chung12.
Abstract
Immune effector responses against Plasmodium falciparum include antibody-mediated activation of innate immune cells, which can induce Fc effector functions, including antibody-dependent cellular cytotoxicity, and the secretion of cytokines and chemokines. These effector functions are regulated by the composition of immunoglobulin G (IgG) Fc N-linked glycans. However, a role for antibody-mediated natural killer (NK) cells activation or Fc N-linked glycans in pregnant women with malaria has not yet been established. Herein, we studied the capacity of IgG antibodies from pregnant women, with placental malaria or non-placental malaria, to induce NK cell activation in response to placental malaria-associated antigens DBL2 and DBL3. Antibody-mediated NK cell activation was observed in pregnant women with malaria, but no differences were associated with susceptibility to placental malaria. Elevated anti-inflammatory glycosylation patterns of IgG antibodies were observed in pregnant women with or without malaria infection, which were not seen in healthy non-pregnant controls. This suggests that pregnancy-associated anti-inflammatory Fc N-linked glycans may dampen the antibody-mediated activation of NK cells in pregnant women with malaria infection. Overall, although anti-inflammatory glycans and antibody-dependent NK cell activation were detected in pregnant women with malaria, a definitive role for these antibody features in protecting against placental malaria remains to be proven.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33602987 PMCID: PMC7893158 DOI: 10.1038/s41598-021-83093-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379